HU-210 je sintetički kanabinoid koji je prvi put sintetisan 1988. iz (1R,5S)-mirtenol]]a[6][7][8][9] HU-210 je 100 do 800 puta potentniji od prirodnog THC iz kanabisa i ima duže vreme dejstva.[10] HU-210 je (–)-1,1-dimetilheptil analog 11-hidroksi- Δ8- tetrahidrokanabinola.
↑Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). "Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities". Annual Reports in Computational Chemistry4: 217–241. doi:10.1016/S1574-1400(08)00012-1.
↑Mechoulam, R., Lander, N., Breuer, A., Zahalka, J. Synthesis of the Individual, Pharmacologically Distinct, Enantiomers of a Tetrahydrocannabinol Derivative. Tetrahedron: Asymmetry. 1990. Vol 1, No 5. pp 315-318.
↑Mechoulam, R. et al. (1988). "Enantiomeric cannabinoids: stereospecificity of psychotropic activity". Experientia44 (9): 762–764. PMID3416993. doi:10.1007/BF01959156.CS1 održavanje: Eksplicitna upotreba et al. (link)
↑Little PJ, Compton DR, Mechoulam R, Martin BR. Stereochemical effects of 11-OH-Δ8-THC-dimethylheptyl in mice and dogs. Pharmacology, Biochemistry, and Behavior. 1989 Mar;32(3):661-666.
↑Järbe, T.; Hiltunen, A.; Mechoulam, R. (1989). "Stereospecificity of the discriminative stimulus functions of the dimethylheptyl homologs of 11-hydroxy-delta 8-tetrahydrocannabinol in rats and pigeons". The Journal of Pharmacology and Experimental Therapeutics250 (3): 1000–1005. PMID2550611.
↑Devane, W. A. et al. (1992). "A novel probe for the cannabinoid receptor". Journal of Medical Chemistry35 (11): 2065–2069. PMID1317925. doi:10.1021/jm00089a018.CS1 održavanje: Eksplicitna upotreba et al. (link)